Results 11 to 20 of about 38,467 (231)

Malignant hyperthermia [PDF]

Korean Journal of Anesthesiology, 2012
Malignant hyperthermia (MH) is an uncommon, life-threatening pharmacogenetic disorder of the skeletal muscle. It presents as a hypermetabolic response in susceptible individuals to potent volatile anesthetics with/without depolarizing muscle relaxants ...
Dong-Chan Kim
doaj   +10 more sources

Malignant Hyperthermia

JAI (Jurnal Anestesiologi Indonesia)
Malignant hyperthermia (MH) is a life-threatening clinical syndrome caused by hypermetabolism involving skeletal muscle. MH is very rare, but it is one of the causes of death in the operating room. MH is an autosomal dominant disease and can be triggered
Watt S, McAllister RK.
europepmc   +4 more sources

Malignant hyperthermia [PDF]

Orphanet Journal of Rare Diseases, 2007
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine ...
Pollock Neil, James Danielle, Davis Mark, Rosenberg Henry, Stowell Kathryn   +4 more
doaj   +3 more sources

Malignant hyperthermia

Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022
Malignant hyperthermia manifests as hypermetabolism of striated voluntary muscle. Generally, this condition occurs during general anesthesia when inhalational anesthetics and succinylcholine are used.
S. N. Ionov, M. V. Sharavina, Yu. S. Makhnycheva   +2 more
doaj   +3 more sources

Malignant hyperthermia: patient undergoing limb debridement surgery-a case report. [PDF]

J Med Case Rep
Background Malignant hyperthermia is a rare but potentially fatal clinical emergency, primarily triggered by inhaled volatile anesthetics. It is associated with inherited autosomal-dominant skeletal muscle disorders and typically caused by mutations in ...
Geng Z, Yang J, Wang A, Chen X, Chen R, Li Z, Zhang X.   +6 more
europepmc   +2 more sources

Successful management of malignant hyperthermia without dantrolene: A case report. [PDF]

J Int Med Res
Malignant hyperthermia during surgery represents a significant challenge for anesthesiologists due to its high mortality rate and the risk of long-term physiological damage.
Zhang C, Wang H, Chen Z, Zhang Y.
europepmc   +2 more sources

Keeping it in the family: malignant hyperthermia - how we predict, recognise and treat it. [PDF]

Braz J Anesthesiol
Bilmen JG, Gupta PK.
europepmc   +2 more sources

Atypical Postoperative Presentation of Malignant Hyperthermia in an Elderly Patient Following Transcatheter Aortic Valve Replacement. [PDF]

Cureus
Knick MW, Nanners B, Abbas Khan MA, Kohli A.   +3 more
europepmc   +3 more sources

Evaluation of anesthesiology residents in the diagnosis and control of malignant hyperthermia: comparison of three scenarios of realistic simulation ‒ a cross-sectional controlled study. [PDF]

Braz J Anesthesiol
Neville MFL, Guimarães de Almeida V, Andrade PV, Santos JM, Munechika M, Ferez D, Dos Santos Silva M, Canga LA, Tripoloni AC, Girard T, da Silva HCA.   +10 more
europepmc   +2 more sources

Acute postoperative sepsis mimicking symptomology suspicious for malignant hyperthermia: case report [PDF]

Revista Brasileira de Anestesiologia, 2020
Background: Sepsis is a life-threatening organ dysfunction with non-specific clinical features that can mimic other clinical conditions with hyper metabolic state such as malignant hyperthermia.
Vendhan Ramanujam, Christopher R. Hoffman, Kevin Russo, Michael S. Green   +3 more
doaj   +5 more sources